↓ Skip to main content

The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence

Overview of attention for article published in Frontiers in Pharmacology, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
3 news outlets
twitter
2 X users

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
Published in
Frontiers in Pharmacology, December 2021
DOI 10.3389/fphar.2021.731453
Pubmed ID
Authors

Tianli Zhang, Xiang Tong, Shijie Zhang, Dongguang Wang, Lian Wang, Qian Wang, Hong Fan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 13%
Student > Master 6 13%
Student > Ph. D. Student 4 8%
Researcher 4 8%
Student > Postgraduate 2 4%
Other 1 2%
Unknown 25 52%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 10%
Medicine and Dentistry 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Immunology and Microbiology 3 6%
Social Sciences 3 6%
Other 4 8%
Unknown 26 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 November 2023.
All research outputs
#1,479,016
of 24,870,516 outputs
Outputs from Frontiers in Pharmacology
#556
of 18,997 outputs
Outputs of similar age
#35,782
of 515,043 outputs
Outputs of similar age from Frontiers in Pharmacology
#30
of 1,160 outputs
Altmetric has tracked 24,870,516 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,997 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 515,043 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 1,160 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.